View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: July 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

The Tile Shop Expands Exclusive Collaboration With Jeffrey Alan Marks,...

The Tile Shop Expands Exclusive Collaboration With Jeffrey Alan Marks, Launching Two New Coastal-Inspired Designs MINNEAPOLIS, June 25, 2025 (GLOBE NEWSWIRE) -- The Tile Shop, a leading specialty retailer of natural stone and specialty tiles, is proud to announce the expansion of its exclusive Jeffrey Alan Marks Collection with the debut of two new tile designs: Natural Zen Birchwood and Sand Dollar. These new designs reflect Marks’ signature California-casual aesthetic and offer customers elevated options for creating timeless, relaxed spaces with natural texture and coastal-i...

 PRESS RELEASE

Alset Inc. Announces Stock Repurchase Program

Alset Inc. Announces Stock Repurchase Program BETHESDA, MD, June 23, 2025 (GLOBE NEWSWIRE) -- Alset Inc. (NASDAQ:AEI) ("AEI" or the "Company"), a diversified holding company principally engaged through its subsidiaries in the development of smart and sustainable home communities and other property development, financial services, digital transformation technologies, biohealth activities and consumer products, is pleased to announce that its Board of Directors has authorized a new stock repurchase program of up to $1,000,000 of the Company’s outstanding common stock. Repurchases under the...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: June 17, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Fluence Validates Safety of Gridstack Pro 5000 in Benchmark-Setting Fi...

Fluence Validates Safety of Gridstack Pro 5000 in Benchmark-Setting Fire Safety Tests Large-scale testing by Fluence and CSA Group shows Gridstack Pro 5000 system, delivering up to 5.6 MWh in a 20-foot enclosure, surpassing current and emerging safety standards  ARLINGTON, Va., June 12, 2025 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. ("Fluence") (NASDAQ: FLNC), a global market leader delivering intelligent energy storage, services, and asset optimization software, today announced the successful completion of one of the largest fire safety evaluations in the energy storage industry. In par...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: June 9, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: June 7, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Merus N.V. gibt Preis für öffentliches Angebot von Stammaktien bekannt

Merus N.V. gibt Preis für öffentliches Angebot von Stammaktien bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts, June 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) („Merus“, das „Unternehmen“, „wir“ und „unser“), ein Onkologieunternehmen, das innovative, multispezifische Antikörper in voller Länge und Antikörper-Wirkstoff-Konjugate (Biclonics®, Triclonics® und ADClonics®) entwickelt, hat heute den Preis eines geplanten öffentlichen Zeichnungsangebots von 5.263.158 Stammaktien zu einem öffentlichen Angebotspreis von 57,00 USD je Aktie (die „Angebotsaktien“) bekanntgegebe...

 PRESS RELEASE

Merus N.V. annonce la fixation du prix de l’offre publique d’actions o...

Merus N.V. annonce la fixation du prix de l’offre publique d’actions ordinaires UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 05 juin 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), ci-après « Merus », la « Société », « nous » ou « notre/nos », une société spécialisée dans l’oncologie développant des anticorps multispécifiques pleine longueur innovants et des conjugués anticorps-médicaments appelés Biclonics®, Triclonics® et ADClonics®, fixe ce jour le prix de lancement de ses 5 263 158 actions ordinaires à 57,00 dollars chacune dans le cadre de son offre publique de souscri...

 PRESS RELEASE

Merus N.V. gibt geplantes öffentliches Zeichnungsangebot von Stammakti...

Merus N.V. gibt geplantes öffentliches Zeichnungsangebot von Stammaktien bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts, June 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) („Merus“, das „Unternehmen“, „wir“ und „unser“), ein Onkologieunternehmen, das innovative, multispezifische Antikörper in voller Länge und Antikörper-Wirkstoff-Konjugate (Biclonics®, Triclonics® und ADClonics®) entwickelt, gab heute den Start eines geplanten öffentlichen Zeichnungsangebots seiner Stammaktien (die „Angebotsaktien“) bekannt. Alle Stammaktien werden von Merus angeboten. Darüber hinaus ...

 PRESS RELEASE

Merus N.V. annonce une offre publique de souscription d’actions ordina...

Merus N.V. annonce une offre publique de souscription d’actions ordinaires UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 05 juin 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS) (« Merus », la « Société », « nous » et « notre »), une société spécialisée dans l’oncologie qui développe des anticorps multispécifiques innovants et des conjugués anticorps-médicaments (Biclonics®, Triclonics® et ADClonics®), a annoncé aujourd’hui le lancement d’une offre publique de souscription de ses actions ordinaires (les « Actions de l’offre »). Toutes les actions ordinaires sont proposées par Merus. E...

Guy Sips ... (+11)
  • Guy Sips
  • Jacob Mekhael
  • Kristof Samoy
  • Livio Luyten
  • Lynn Hautekeete
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi

Dynamic Top Pick List Update June: Removing Merus, Shurgard and Adyen ...

In this June update, we've made four adjustments to the KBC Securities Dynamic Top Pick List: 1.Merus (Removed – 27 May) was removed following the release of strong interim Phase 2 data at the ASCO 2025 conference. Its lead asset, petosemtamab, in combination with Keytruda, showed a 63% overall response rate in first-line treatment of head and neck cancer—significantly outperforming Keytruda monotherapy. The resulting share price surge validated our investment thesis. 2. Adyen (Removed) has de...

Thomas Vranken
  • Thomas Vranken

Merus Raises $ 300m through public offering

Merus has announced a public offering of 5.26m shares at $57 per share, an 8.6% discount to the previous close, to raise approx. $300 million in gross proceeds. The proceeds from the offering will fund clinical and preclinical development, technology advancement, and general corporate needs. Following strong ASCO 2025 data and a resulting share price increase, the transaction strengthens Merus' financial position beyond its solid 1Q25 cash position of $638m. We have raised the probability of suc...

Guy Sips ... (+6)
  • Guy Sips
  • Jacob Mekhael
  • Livio Luyten
  • Lynn Hautekeete
  • Thomas Vranken
  • Wim Lewi
 PRESS RELEASE

Merus N.V. Announces Pricing of Public Offering of Common Shares

Merus N.V. Announces Pricing of Public Offering of Common Shares UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics®, Triclonics® and ADClonics®), today announced the pricing of an underwritten public offering of 5,263,158 common shares, at a public offering price of $57.00 per share (the “Offer Shares”). Merus also granted the underwriters a 30-day option to purchase up to ...

 PRESS RELEASE

Merus N.V. Announces Proposed Public Offering of Common Shares

Merus N.V. Announces Proposed Public Offering of Common Shares UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics®, Triclonics® and ADClonics®), today announced the launch of a proposed underwritten public offering of its common shares (the “Offer Shares”). All of the common shares are being offered by Merus. In addition, Merus expects to grant the underwriters a 30-day opti...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: May 31, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: May 29, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: May 28, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

U.S. Senator John Curtis Visits Utah Manufacturing Facility Producing ...

U.S. Senator John Curtis Visits Utah Manufacturing Facility Producing Fluence Battery Modules; Highlights Energy Jobs and Domestic Battery Supply Chain ARLINGTON, Va., May 28, 2025 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (“Fluence”) (Nasdaq: FLNC), a global market leader delivering intelligent energy storage systems, operational services, and asset optimization software, welcomed U.S. Senator John Curtis (R-UT) to the Utah-based manufacturing facility that is producing Fluence’s battery modules. The visit spotlighted Fluence’s growing investment in U.S.-based manufacturing and its leader...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch